Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin
1996

Preventing Nausea After Chemotherapy

Sample size: 70 publication Evidence: moderate

Author Information

Author(s): K Matsui, M Fukuoka, M Takada, Y Kusunoki, T Yana, K Tamura, T Yoshida, K Jida, T Hirashima, H Tsukada, S Ushijima, H Miyawaki, N Masuda

Primary Institution: Osaka Prefectural Habikino Hospital

Hypothesis

A combination of granisetron, dexamethasone, and prochlorperazine is more effective than granisetron alone in preventing delayed emesis in patients receiving high-dose cisplatin.

Conclusion

The combination of granisetron, dexamethasone, and prochlorperazine was found to be more effective than granisetron alone in preventing delayed emesis after high-dose cisplatin.

Supporting Evidence

  • The combination regimen showed superior rates of complete plus major responses of 77% compared to 51% for granisetron alone.
  • Treatment arm was the only significant determinant factor for the occurrence of delayed emesis.
  • The study included 70 patients who were all eligible for the trial.

Takeaway

This study shows that using a mix of three medicines helps stop patients from feeling sick after chemotherapy better than just one medicine.

Methodology

A prospective randomized trial comparing the efficacy and toxicity of a combination regimen versus granisetron alone in controlling cisplatin-induced delayed emesis.

Limitations

The study had a relatively small sample size and may not be generalizable to all patient populations.

Participant Demographics

Sixty-eight patients had lung cancer and two had colon cancer with lung metastases; all were cisplatin-naive.

Statistical Information

P-Value

0.0460

Confidence Interval

95% confidence interval, 34-69%

Statistical Significance

p=0.0460

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication